Novian Health, the developer of Novilase breast therapy, has announced the issuance of a new US patent covering the interstitial laser therapy in combination with interstitial brachytherapy treatment. Novian Health has developed the ...
Tags: Novian Health, Breast Cancer
Jarvik Heart, a manufacturer of cardiac assist devices, has announced the Shonin approval from the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) for the Jarvik 2000 heart, a small left ventricular assist device implanted inside ...
Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...
Tags: Diabetes Drug, Medicine
Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013. Currently both the firms are working on additional agreements for ...
Tags: Teva Licenses, Medicine
Ventana Medical Systems, a member of the Roche Group, has obtained the US Food and Drug Administration’s (FDA) 510(k) approval for its Companion Algorithm ER (SP1) image analysis algorithm used with the Ventana iScan Coreo scanner ...
Tags: Breast Cancer, Analysis Algorithm
Medtronic, a medical technology company, has announced CE Mark approval in Europe and Therapeutic Goods Administration (TGA) listing in Australia for its Symplicity Spyral catheter and Symplicity G3 radio frequency (RF) generator. ...
Tags: Medtronic, medical technology
HOUSTON — Mattress Firm has appointed industry veteran and philanthropist Roger Magowitz executive director of the Mattress Firm Foundation. He will oversee the day-to-day operations of the foundation, which raises awareness and funds ...
Tags: Mattress Firm, Roger Magowitz, Mattress Firm Foundation, appointment
Roche announced has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for the use of four additional specimen types with the cobas CT/NG v2.0 test to help physicians diagnose Chlamydia trachomatis (CT) and Neisseria ...
US-based TYRX has obtained an approval from the US Food and Drug Administration (FDA) for expanded indications in marketing the AIGISRx N antibacterial envelope for use with spinal cord neuromodulators. Recently, TYRX has also obtained an ...
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
Bolton Medical, a medical device manufacturer, has initiated its Phase II US clinical trial to study the safety and effectiveness of the Treovance abdominal stent-graft with Navitel delivery system. The first two cases were performed on ...
PrimeraDx, a molecular diagnostics company, has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its ICEPlex C. difficile assay kit and the ICEPlex system. The ICEPlex system is a multiplex real-time PCR system ...
NanoViricides has received results of detailed lab analysis studies from the initial non-GLP toxicology studies of intravenously administered FluCide. No overt adverse safety and toxicology effects were observed in this study of the ...
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug